Sonic Healthcare Limited
SHL
Clasificación en acciones
#2864
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Precio por acción
$13.23
Capitalización bursátil
$6.54B
Cambio (1 día)
-0.40%
Cambio (1 año)
-4.66%
País
AU
Comercio Sonic Healthcare Limited (SHL)
Categoría
Healthcare
Ganancias de Sonic Healthcare Limited (SHL)
Ganancias en Jun 2026 TTM: $581.53M
Secondo gli ultimi rapporti finanziari di Sonic Healthcare Limited, gli utili attuali della società sono $581.53M. Nel 2024, la società ha registrato un utile di $487.85M, una disminución en comparación con agli utili del 2023, che erano di $620.44M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Sonic Healthcare Limited desde 2000 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $581.53M | 17.65% |
| 2025 | $494.30M | 1.32% |
| 2024 | $487.85M | -21.37% |
| 2023 | $620.44M | -56.70% |
| 2022 | $1.43B | 4.50% |
| 2021 | $1.37B | 184.25% |
| 2020 | $482.35M | -4.91% |
| 2019 | $507.24M | 11.00% |
| 2018 | $456.95M | 3.07% |
| 2017 | $443.36M | -0.42% |
| 2016 | $445.22M | 24.81% |
| 2015 | $356.72M | -26.56% |
| 2014 | $485.74M | 19.92% |
| 2013 | $405.04M | -5.17% |
| 2012 | $427.14M | 2.04% |
| 2011 | $418.61M | 27.85% |
| 2010 | $327.42M | 62.12% |
| 2009 | $201.96M | -36.56% |
| 2008 | $318.35M | 29.08% |
| 2007 | $246.63M | 25.90% |
| 2006 | $195.89M | 69.95% |
| 2005 | $115.26M | 60.97% |
| 2004 | $71.61M | 36.20% |
| 2003 | $52.57M | 41.85% |
| 2002 | $37.06M | 31.08% |
| 2001 | $28.27M | 16.52% |
| 2000 | $24.26M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $7.61B | 1,208.44% |
US
|
|
| $4.76B | 718.87% |
US
|
|
| $-252.70M | -143.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 185.11% |
US
|
